跳转至内容
Merck

855775P

Avanti

18:0 Lyso PC

Avanti Research - A Croda Brand

别名:

1-十八酰基 -sn-甘油-3-磷酰胆碱;PC(18:0/0:0)

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C26H54NO7P
CAS号:
分子量:
523.68
分類程式碼代碼:
51191904
NACRES:
NA.25

描述

1-stearoyl-2-hydroxy-sn-glycero-3-phosphocholine

化驗

>99% (LPC; may contain up to 10% of the 2-LPC isomer, TLC)

形狀

powder

包裝

pkg of 1 × 1 g (855775P-1g)
pkg of 1 × 200 mg (855775P-200mg)
pkg of 1 × 25 mg (855775P-25mg)
pkg of 1 × 500 mg (855775P-500mg)

製造商/商標名

Avanti Research - A Croda Brand

運輸包裝

dry ice

儲存溫度

−20°C

SMILES 字串

O[C@](COP([O-])(OCC[N+](C)(C)C)=O)([H])COC(CCCCCCCCCCCCCCCCC)=O

InChI

1S/C26H54NO7P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-26(29)32-23-25(28)24-34-35(30,31)33-22-21-27(2,3)4/h25,28H,5-24H2,1-4H3

InChI 密鑰

IHNKQIMGVNPMTC-UHFFFAOYSA-N

應用

18:0 Lyso Pc已被用于:
  • 官能化碳纳米管 (CNT),用于开发DNA和CNT结合方法。
  • 提高小鼠溶血磷脂酸 (LPA) 水平。
  • 诱导TNF受体相关因子3相互作用蛋白2 (TRAF3IP2) 的内皮细胞 (EC) 表达。

包裝

20 mL透明玻璃螺旋盖小瓶(855775P-1g)
20 mL透明玻璃螺旋盖小瓶(855775P-500mg)
5 mL琥珀色玻璃螺旋盖小瓶(855775P-200mg)
5 mL琥珀色玻璃螺旋盖小瓶(855775P-25mg)

法律資訊

Avanti Research is a trademark of Avanti Polar Lipids, LLC

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

OxLDL induces endothelial dysfunction and death via TRAF3IP2: inhibition by HDL3 and AMPK activators
Valente AJ, et al.
Free radical biology & medicine, 70, 117-128 (2014)
Optimising DNA binding to carbon nanotubes by non-covalent methods
Vanesa Sanz
Carbon, 49(5), 1775-1781 (2011)
Anthony J Valente et al.
Free radical biology & medicine, 70, 117-128 (2014-02-25)
Oxidized low-density lipoprotein (oxLDL) induces endothelial cell death through the activation of NF-κB and AP-1 pathways. TRAF3IP2 is a redox-sensitive cytoplasmic adapter protein and an upstream regulator of IKK/NF-κB and JNK/AP-1. Here we show that oxLDL-induced death in human primary
Dumindika A Siriwardane et al.
International journal of pharmaceutics, 578, 119077-119077 (2020-01-29)
Identification and quantification of excipient related degradation products in the liposomal formulation is important, as they may impact the safety and efficacy of the drug. Phospholipids are one of the major excipients in liposome drugs composing the lipid bilayer, and
Otto K Kari et al.
Nanoscale, 12(3), 1728-1741 (2020-01-03)
Methodological constraints have limited our ability to study protein corona formation, slowing nanomedicine development and their successful translation into the clinic. We determined hard and soft corona structural properties along with the corresponding proteomic compositions on liposomes in a label-free

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门